
Opinion|Videos|August 29, 2024
Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
A panel of experts on chronic myeloid leukemia discuss common patient concerns, adverse effect considerations, and best practices for setting clear expectations.
Advertisement
Episodes in this series

This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following questions:
- What are some of the most common concerns or questions newly diagnosed CML patients may have about their initial treatment plan?
- What are some common adverse effects or tolerability challenges patients may experience with their initial treatment plan?
- What is your best practice to set clear expectations with your patients on what they may experience along their CML journey?
Advertisement
Related to this article

The approval expands the indication of pirtobrutinib to patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma with no known 17p deletion.
Advertisement
Advertisement
Trending on CancerNetwork
1
EXCALIBER-RRMM: Iberdomide in Relapsed/Refractory Multiple Myeloma
2
Prioritizing Proton Therapy for Pelvic Nodal Irradiation in Prostate Cancer
3
Alliance A071801 Supports Fractionated SRS After Brain Metastasis Surgery
4
FDA OKs Pirtobrutinib in Frontline CLL/SLL
5

